1 RNA modifications: importance in immune cell biology and related diseases
来源:SIGNAL TRANSDUCT TAR( P 2095-9907 E 2059-3635 ) 发表时间: 2022/09
类型:期刊论文 为本人加分:7734.464651
贡献度:共同通讯作者
2 Advances in the pathogenesis of psoriasis: from keratinocyte perspective
来源:CELL DEATH DIS( P 2041-4889 E ) 发表时间: 2022/01
类型:期刊论文 为本人加分:4643.081020
贡献度:共同通讯作者
3 IL-21 Induces an Imbalance of Th17/Treg Cells in Moderate-to-Severe Plaque Psoriasis Patients
来源:FRONT IMMUNOL( P 1664-3224 E ) 发表时间: 2019/08
类型:期刊论文 为本人加分:4131.102694
贡献度:共同第一作者;共同通讯作者
4 Infliximab and biosimilar infliximab in psoriasis: efficacy, loss of efficacy, and adverse events
来源:DRUG DES DEV THER( P 1177-8881 E ) 发表时间: 2019/01
类型:期刊论文 为本人加分:3407.889930
贡献度:单独通讯作者
5 Efficacy and safety of biologics targeting IL-17 and IL-23 in the treatment of moderate-to-severe pl..
来源:INT IMMUNOPHARMACOL( P 1567-5769 E 1878-1705 ) 发表时间: 2018/09
类型:期刊论文 为本人加分:3336.585285
贡献度:单独通讯作者
6 Microneedles: a potential strategy in transdermal delivery and application in the management of psor..
来源:RSC ADV( P E 2046-2069 ) 发表时间: 2020/04
类型:期刊论文 为本人加分:2982.451064
贡献度:单独通讯作者
7 The tumor necrosis factor receptor superfamily member 1B polymorphisms predict response to anti-TNF ..
来源:INT IMMUNOPHARMACOL( P 1567-5769 E 1878-1705 ) 发表时间: 2015/09
类型:期刊论文 为本人加分:2856.529239
贡献度:单独通讯作者
8 A Review of Switching Biologic Agents in the Treatment of Moderate-to-Severe Plaque Psoriasis
来源:CLIN DRUG INVEST( P 1173-2563 E 1179-1918 ) 发表时间: 2018/03
类型:期刊论文 为本人加分:2641.203204
贡献度:单独通讯作者
9 Current Research and Use of Mesenchymal Stem Cells in the Therapy of Autoimmune Diseases
来源:CURR STEM CELL RES T( P 1574-888X E 2212-3946 ) 发表时间: 2019/01
类型:期刊论文 为本人加分:2550.782821
贡献度:单独通讯作者
10 High-throughput transcriptome and pathogenesis analysis of clinical psoriasis
来源:J DERMATOL SCI( P 0923-1811 E 1873-569X ) 发表时间: 2020/05
类型:期刊论文 为本人加分:2258.925281
贡献度:单独通讯作者